Vascular Disease and Surgery


Heart transplantation surgery has become the standard treatment for selected patients with end-stage heart failure. Improvements in immunosuppressant, donor procurement, surgical techniques, and post-transplant care have resulted in a substantial decrease in acute allograft rejection, which had previously significantly limited survival of heart transplant recipients.

The number of heart transplants performed worldwide over the last decade has continued to increase annually.

Current challenges include older age of both recipients and donors; an increasing number of transplants performed with mechanical circulatory support; the growing use of combined organ transplants (now more than 4% of all heart transplants); and a high proportion of sensitised patients (those with pre-formed antibodies against human leukocyte antigens, which increased the risk of organ rejection).

Related Articles


Paclitaxel Exposure and Dosage of Drug-coated Devices for Fempop PAD

Ceazón T Edwards, Peter A Schneider, Cindy Huynh,


Citation: Vascular & Endovascular Review 2021;4:e05.

Coil Migration to the Right Ventricle Following Pelvic Vein Embolisation

Luca Scott, Jack Cullen,


Citation: Vascular & Endovascular Review 2021;4:e04.

Paclitaxel- and Sirolimus-coated Balloons in PAD Treatment

Masayuki Mori, Atsushi Sakamoto, Rika Kawakam,


Citation: Vascular & Endovascular Review 2021;4:e03.

Endovascular Treatment of Giant Visceral Aneurysms: An Overview

Davide Castiglione, Marcello Andrea Tipaldi, Michele Rossi,


Citation: Vascular & Endovascular Review 2021;4:e01.